MetaADEDB 2.0 @ LMMD
ulipristal acetate
(OOLLAFOLCSJHRE-ZHAKMVSLSA-N)
Structure
SMILES
CC(=O)O[C@@]1(CC[C@@H]2[C@]1(C)C[C@H](c1ccc(cc1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@H]21)C(=O)C
Molecular Formula:
C30H37NO4
Molecular Weight:
475.619
Log P:
5.5430
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
0
TPSA:
63.68
CAS Number(s):
126784-99-4
Synonym(s)
1.
ulipristal acetate
2.
(11beta)-17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-19-norpregna-4,9-diene-3,20-dione
3.
Ella norpregnadiene
4.
Esmya
External Link(s)
MeSHC555622
PubChem Compound130904
BindingDB50375424
ChEBI71025
CHEMBLCHEMBL260538
DrugCentral4166
IUPHAR/BPS Guide to PHARMACOLOGY7460
KEGGdr:D09687
ZINC3920657
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Pregnancy after post coital contraceptionFAERS: 38US FAERS
2Maternal exposure during pregnancyFAERS: 26US FAERS
3Maternal exposure before pregnancyFAERS: 8US FAERS
4PregnancyFAERS: 8US FAERS
5Drug ineffectiveFAERS: 5US FAERS
6Ectopic PregnancyFAERS: 5US FAERS
7Maternal exposure timing unspecifiedFAERS: 5US FAERS
8Pregnancy test positiveFAERS: 5US FAERS
9Abdominal PainFAERS: 3US FAERS
10MenorrhagiaFAERS: 3US FAERS
11Pregnancy on oral contraceptiveFAERS: 3US FAERS
12ThrombosisFAERS: 3US FAERS
13Blighted ovumFAERS: 2US FAERS
14Cerebrovascular accidentFAERS: 2US FAERS
15Drug exposure during pregnancyFAERS: 2US FAERS
16Urinary tract infectionFAERS: 2US FAERS
17treatment failureFAERS: 2US FAERS
18Abdominal discomfortFAERS: 1US FAERS
19AcneFAERS: 1US FAERS
20AnxietyFAERS: 1US FAERS
21Breech PresentationFAERS: 1US FAERS
22BronchitisFAERS: 1US FAERS
23Cerebral InfarctionFAERS: 1US FAERS
24Contraindicated drug administeredFAERS: 1US FAERS
25DeafnessFAERS: 1US FAERS
26Deep Vein ThrombosisFAERS: 1US FAERS
27DizzinessFAERS: 1US FAERS
28EndometriosisFAERS: 1US FAERS
29FatigueFAERS: 1US FAERS
30HeadacheFAERS: 1US FAERS
31Human chorionic gonadotropin increasedFAERS: 1US FAERS
32Inappropriate schedule of drug administrationFAERS: 1US FAERS
33Myasthenia GravisFAERS: 1US FAERS
34NauseaFAERS: 1US FAERS
35PainFAERS: 1US FAERS
36Placenta AccretaFAERS: 1US FAERS
37Product packaging quantity issueFAERS: 1US FAERS
38Ruptured ectopic pregnancyFAERS: 1US FAERS
39Unwanted pregnancyFAERS: 1US FAERS
40Vaginal DischargeFAERS: 1US FAERS
41Vanishing twin syndromeFAERS: 1US FAERS
42VertigoFAERS: 1US FAERS
43VomitingFAERS: 1US FAERS
44Vulvovaginal painFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.